Stream every public session from the 27th annual Global Conference right here on our website.

Watch Here
results for:

Content Type

Centers and Programs

Topics

Tags

Refine by Date

11
June Cha staff
June Cha
June Cha is a policy director at FasterCures, MI Health.
Apr 23, 2024
Research Partnership Maturity Model landing page
Research Partnership Maturity Model
FasterCures created the Research Partnership Maturity Model (RPMM) toolkit to enable patient organiz
ations that support or conduct research to 1) understand their assets and capab, Access the Model Visualization and Companion Guide , Tools You Can Use This collection of tools provides resources aligned to the RPMM domains, and examples that can support the growth of patient organizations hoping to build their capacity in
Jul 29, 2021
FasterCures Quarterly Update—April 2024 article
FasterCures Quarterly Update—April 2024
In This Newsletter New FasterCures Team Member Policy Updates Events and Convenings Recap FasterCur
es in the Community
Apr 11, 2024
MI Health landing page
MI Health
MI Health bridges innovation gaps across the health and health-care continuum. We advance whole-pers
on health throughout the life span by improving healthy aging, public health, biomedical science, and food systems., Future of Health Summit Panels The Milken Institute Future of Health Summit brought together hundreds of leaders from across sectors to discuss critical issues and solutions within reach for , ,
Apr 23, 2024
The 2024-2025 FasterCures LeadersLink Cohort article
The 2024-2025 FasterCures LeadersLink Cohort
The 2024–2025 FasterCures’ LeadersLink program cohort has been carefully selected from a highly comp
etitive pool of candidates.
Apr 23, 2024
TRAIN Newsletter — April 2024 article
TRAIN Newsletter — April 2024
TRAIN eNews is delivered directly to organizations participating in The Research Acceleration and In
novation Network (TRAIN).
Apr 22, 2024
Mapping the Patient and Caregiver Journey for Cell and Gene Therapies article
Mapping the Patient and Caregiver Journey for Cell and Gene Therapies
Introduction Advances in cell and gene therapies are transforming how we treat or potentially cure
disease. Cell and gene therapies aim to address the underlying cause of genetic and acquired diseases.
Jul 30, 2021
Comments on Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products, Federal Register Docket FDA-2016-D-3561 article
Comments on Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products, Federal Register Docket FDA-2016-D-3561
Lauren K. Roth Associate Commissioner for Policy Food and Drug Administration 5630 Fishers Lane, Rm.
1061 Rockville, MD 20852 Dear Ms. Roth,
Apr 29, 2024
Comment Letter: Advanced Research Projects Agency for Health (ARPA-H) Request for Information article
Comment Letter: Advanced Research Projects Agency for Health (ARPA-H) Request for Information
Submitted electronically The Honorable Diana DeGette US House of Representatives Washington, DC 205
15 The Honorable Fred Upton US House of Representatives Washington, DC 20515
Jul 16, 2021
Building Impactful, Transparent, and Reciprocal Relationships with Industry Partners video
Building Impactful, Transparent, and Reciprocal Relationships with Industry Partners
How can patient organizations hoping to leverage the resources of industry researchers attract the
ir support and establish formal industry partnerships?
Apr 3, 2024
Comment Letter: Office of Management and Budget (OMB) – Practices for Advancing Equity and Support for Underserved Communities article
Comment Letter: Office of Management and Budget (OMB) – Practices for Advancing Equity and Support for Underserved Communities
Submitted electronically To: The Honorable Shalanda Young, Acting Director, Office of Management an
d Budget From: Richard Ditizio, President and Chief Operating Officer, Milken Institute
Jul 6, 2021